PSMD10P3

Across TCGA pan-cancer cohorts, PSMD10P3 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of PSMD10P3’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where PSMD10P3 RNA is repressed in tumor relative to normal tissue. In most cancer types PSMD10P3 is over-expressed in tumor, although a few such as BLCA show the opposite, repressed pattern.

BLCA, UCEC, and STAD are the cancer types where PSMD10P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PSMD10P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Female	III,IV	−0.090	.020	3	view →
UCEC	All	II,III,IV	+0.183	.048	2	view →
STAD	All	All	+0.108	.046	2	view →
BRCA	All	All	+0.040	.047	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

PSMD10P3–BLCA

Open the BLCA breakdown →